Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Patient preferences for the chemoprevention of colorectal cancer
Chin Hur
, Darcy E. Broughton
,
Chung Yin Kong
, Elissa M. Ozanne
, Ethan B. Richards
, Thanh Truong
, G. Scott Gazelle
Research output
:
Contribution to journal
›
Article
›
peer-review
4
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Patient preferences for the chemoprevention of colorectal cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Aspirin
100%
Colorectal Cancer
100%
Patient Preference
100%
Chemoprevention
100%
Celecoxib
85%
Myocardial Infarction
14%
Colorectal Cancer Risk
14%
Colorectal Cancer Prevention
14%
Computer-based
14%
Gastrointestinal Events
14%
Educational Component
14%
Base Condition
14%
Nursing and Health Professions
Patient Preference
100%
Chemoprophylaxis
100%
Colorectal Carcinoma
100%
Celecoxib
100%
Base
16%
Heart Infarction
16%
Side Effect
16%
Decision-Making
16%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
100%
Colorectal Carcinoma
100%
Preference
100%
Celecoxib
85%
Base
14%
Heart Infarction
14%
Side Effect
14%
Neuroscience
Aspirin
100%
Celecoxib
85%
Decision-Making
14%
Myocardial Infarction
14%
Side Effect
14%
Biochemistry, Genetics and Molecular Biology
Patient Preference
100%
Celecoxib
100%
Patient Decision Making
16%
Immunology and Microbiology
Colorectal Carcinoma
100%
Patient Decision Making
33%